Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
de decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 de » 2 d (Expand Search), _ de (Expand Search), i de (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
de decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 de » 2 d (Expand Search), _ de (Expand Search), i de (Expand Search)
-
1741
Why Does the Photoluminescence Efficiency Depend on Excitation Energy in Case of a Quantum Dot? A Case Study of CdSe-Based Core/Alloy Shell/Shell Quantum Dots Employing Ultrafast P...
Published 2019“…The magnitude of the normalized transient population has been shown to increase more than 5-fold with decreasing the excitation energy. For high energy excitation cooling of the exciton (predominantly electron) to band edge is much slower (rise time of ∼526 fs) in comparison to low energy excitation (rise time of <∼100 fs). …”
-
1742
-
1743
-
1744
Synthesis and Properties of Calcium Tetraorganylalanates with [Me<sub>4−<i>n</i></sub>AlPh<sub><i>n</i></sub>]<sup>−</sup> Anions
Published 2008“…With an increasing number of methyl groups the melting points decrease from 210 °C for the tetraphenylalanate <b>2</b> to 20 °C for the tetramethylalanate <b>6</b>.…”
-
1745
-
1746
-
1747
-
1748
-
1749
Trends in Statin Use in Seniors 1999 to 2013: Time Series Analysis
Published 2016“…The overall proportion of NSSPP beneficiaries dispensed a statin increased approximately 4-fold during the study period. …”
-
1750
-
1751
-
1752
-
1753
-
1754
-
1755
-
1756
-
1757
-
1758
-
1759
-
1760
Table_1_Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease.XLSX
Published 2018“…In the present study, we have evaluated the effect of a 6-month treatment of APPsw/PS1dE9 mice with the potent and selective A<sub>2A</sub>R antagonist MSX-3 from 3 to 9-10 months of age. …”